550 related articles for article (PubMed ID: 23889707)
21. The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
Gesuita R; Skrami E; Bonfanti R; Cipriano P; Ferrito L; Frongia P; Iafusco D; Iannilli A; Lombardo F; Mozzillo E; Paleari R; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Carle F; Cherubini V
Pediatr Diabetes; 2017 May; 18(3):241-248. PubMed ID: 26990605
[TBL] [Abstract][Full Text] [Related]
22. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
[TBL] [Abstract][Full Text] [Related]
23. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.
Ziegler R; Heidtmann B; Hilgard D; Hofer S; Rosenbauer J; Holl R;
Pediatr Diabetes; 2011 Feb; 12(1):11-7. PubMed ID: 20337978
[TBL] [Abstract][Full Text] [Related]
24. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
[TBL] [Abstract][Full Text] [Related]
26. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
[TBL] [Abstract][Full Text] [Related]
27. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus.
Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R
Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874
[TBL] [Abstract][Full Text] [Related]
29. Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.
Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Gevers EF; Stephenson T
Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295580
[TBL] [Abstract][Full Text] [Related]
30. Children with type 1 diabetes of early age at onset - immune and metabolic phenotypes.
Sales Luis M; Alcafache M; Ferreira S; Fitas AL; Simões Pereira J; Caramalho Í; Lopes L; Limbert C
J Pediatr Endocrinol Metab; 2019 Sep; 32(9):935-941. PubMed ID: 31280235
[TBL] [Abstract][Full Text] [Related]
31. Current clinical status, glucose control, and complication rates of children and youth with type 1 diabetes in Rwanda.
Marshall SL; Edidin D; Sharma V; Ogle G; Arena VC; Orchard T
Pediatr Diabetes; 2013 May; 14(3):217-26. PubMed ID: 23279222
[TBL] [Abstract][Full Text] [Related]
32. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network.
Clapin HF; Earnest A; Colman PG; Davis EA; Jefferies C; Anderson K; Chee M; Bergman P; de Bock M; Kao KT; Fegan PG; Holmes-Walker DJ; Johnson S; King BR; Mok MT; Narayan K; Peña Vargas AS; Sinnott R; Wheeler BJ; Zimmermann A; Craig ME; Couper JJ;
Diabetes Care; 2022 Dec; 45(12):2918-2925. PubMed ID: 36749868
[TBL] [Abstract][Full Text] [Related]
33. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
34. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
[TBL] [Abstract][Full Text] [Related]
35. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring.
Addala A; Ding V; Zaharieva DP; Bishop FK; Adams AS; King AC; Johari R; Scheinker D; Hood KK; Desai M; Maahs DM; Prahalad P;
JAMA Netw Open; 2023 Apr; 6(4):e238881. PubMed ID: 37074715
[TBL] [Abstract][Full Text] [Related]
36. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
37. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.
Dovc K; Telic SS; Lusa L; Bratanic N; Zerjav-Tansek M; Kotnik P; Stefanija MA; Battelino T; Bratina N
Diabetes Technol Ther; 2014 Jan; 16(1):33-40. PubMed ID: 24131373
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
Raviteja KV; Kumar R; Dayal D; Sachdeva N
Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
[TBL] [Abstract][Full Text] [Related]
39. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.
Hathout EH; Fujishige L; Geach J; Ischandar M; Maruo S; Mace JW
Diabetes Technol Ther; 2003; 5(5):801-6. PubMed ID: 14633345
[TBL] [Abstract][Full Text] [Related]
40. Episodes of severe hypoglycemia is associated with a progressive increase in hemoglobin A1c in children and adolescents with type 1 diabetes.
Pilgaard KA; Breinegaard N; Johannesen J; Pörksen S; Fredheim S; Madsen M; Kristensen K; Svensson J; Birkebaek NH
Pediatr Diabetes; 2020 Aug; 21(5):808-813. PubMed ID: 32304129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
